The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.

[1]  R. Powers,et al.  High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor. , 2000, Journal of molecular biology.

[2]  R. Powers,et al.  Letter to the Editor: 1H, 15N, 13C, and 13CO assignments and secondary structure determination of collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor , 2000, Journal of biomolecular NMR.

[3]  S. George.  Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis , 2000, Expert opinion on investigational drugs.

[4]  B. Fingleton,et al.  Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Decicco,et al.  Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha. , 1999, Journal of medicinal chemistry.

[6]  Michael P. Winters,et al.  New N- and O-arylations with phenylboronic acids and cupric acetate , 1998 .

[7]  K. Bottomley,et al.  Matrix metalloproteinase inhibitors in arthritis. , 1998, Journal of enzyme inhibition.

[8]  J. Dijoseph,et al.  Dialysis tubing implant assay in the rat: A novel in vivo method for identifying inhibitors of matrix metalloproteinases , 1998 .

[9]  R. Huber,et al.  Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Wilson,et al.  Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits. , 1997, Journal of medicinal chemistry.

[11]  J. Bishop,et al.  Ro 32‐3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo , 1997, British journal of pharmacology.

[12]  S. Buchwald,et al.  A Simple Catalytic Method for the Conversion of Aryl Bromides to Arylamines , 1995 .

[13]  J. Bishop,et al.  A novel in vivo model for the study of cartilage degradation. , 1993, Journal of pharmacological and toxicological methods.

[14]  J. Feder,et al.  Spectrophotometric assay for vertebrate collagenase. , 1985, Analytical biochemistry.

[15]  R. Powers,et al.  The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position. , 2001, Bioorganic & medicinal chemistry letters.